抗体 - 药物结合剂由德鲁克斯泰坎驱动:瘤学的创新和挑战
Jung Yoon Jang1, Donghwan Kim2, Na Kyeong Lee1
1Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea.
International journal of molecular sciences
|July 12, 2025
概括
基于德鲁克斯泰康 (DXd) 的抗体-药物联合体 (ADC) 在治疗HER2,HER3和TROP2表达性癌症方面显示出很大的前景. 本综述涵盖了它们的机制,临床成功以及未来优化方面的挑战.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADCs) 在向癌症治疗方面取得了重大进展.
- 基于德鲁克斯泰康 (DXd) 的ADC已经成为一种高度有效的类别,特别是在HER2,HER3和TROP2阳性固体瘤中.
研究的目的:
- 审查与基于DXd的ADC相关的作用机制,临床进展和挑战.
- 突出基于DXd的ADCs在精密瘤学中的变革性影响.
- 探索未来的方向,以提高这些疗法的有效性和可访问性.
主要方法:
- 关于基于DXd的ADCs的临床前和临床研究的文献综述.
- 对药物机制的分析,包括拓酶I抑制和链接器技术.
- 对已批准和正在研究的基于DXd的ADC进行临床试验数据的评估.
主要成果:
- 基于DXd的ADC在乳腺,肺,胃和其他固体瘤中表现出显著的疗效.
- 特拉斯图祖马布德鲁克斯坦和达托帕马布德鲁克斯坦是成功的DXd基ADC的主要例子.
- 主要目标包括HER2,HER3和TROP2,正在进行的研究正在扩大它们的应用.
结论:
- 基于DXd的ADC提供了改进的治疗指数,并彻底改变了精确瘤学.
- 尽管取得了成功,但毒性,耐药性和制造方面的挑战需要进一步调查.
- 未来的研究应该专注于优化DXd-ADC的疗效,克服耐药性,并改善制造以获得更广泛的患者.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K